- Global Pharma News & Resources

Angina Market to Witness Tremendous Growth in Forecasted Period 2021-2028 || Sanofi, Gilead, AstraZeneca, Pfizer Inc., Eli Lilly, Amgen, GlaxoSmithKline

DBMR has added a new report titled Angina Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from consistent sources such as websites, annual reports of the companies, and journals which is then checked and validated by the market experts. Angina Market report has been structured with transparent research studies which makes it of supreme quality. By exactly understanding customer requirement, one or more methods are used to construct this finest market research report. The report provides with CAGR value fluctuation during the forecast period of 2021 – 2028 for the market.

Angina market is expected to gain market growth in the forecast period of 2021 to 2027. Data Bridge Market Research analyses the market to account to USD 14,456.58 million by 2027 growing at a CAGR of 5.90% in the above-mentioned forecast period. The growing geriatric population will help in driving the growth of the angina market.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @

Major Players:-

Sanofi, Gilead, AstraZeneca, Pfizer Inc., Eli Lilly, Amgen, GlaxoSmithKline, Novartis AG, Forest Laboratories In, F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Company, Bayer AG, Abbott Laboratories Inc, Saneron CCEL Therapeutics, Inc, Vasomedical, Inc, Cryopraxis, Neovasc Inc, Ark Therapeutics Group plc, among other domestic and global players.

Competitive Landscape and Angina Market Share Analysis

Angina market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to angina market.

Development of biosimilars and biobetters, increase in diabetic and hypertension population due to bad lifestyle and increase in consumption of alcohol and smoking will likely to accelerate the growth of the angina market in the forecast period of 2020-2027. Downward pricing pressure owing to its commodity nature will likely to hamper the growth of the angina market in the above mentioned forecast period.

This angina market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market.

Global Angina Market Scope and Market Size

Angina market is segmented on the basis of drug class, types and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on drug class, the angina market is segmented into beta blockers, nitrates & calcium channel blockers, angiotensin-converting enzyme inhibitors and others. Drug class are further classified into nitrates, anti-anginal, and ACE inhibitors.
  • On the basis of types, the angina market is segmented into stable angina and unstable angina, variant (prinzmetal) angina and microvascular angina.
  • Based on end-users, the angina market is segmented into hospitals, cardiology centers and others.

For More Insights Get FREE Detailed TOC @

Angina Market Country Level Analysis

Angina market is analysed and market size insights and trends are provided by country, drug class, types and end user as referenced above.

The countries covered in the angina market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the angina market due to the well-developed healthcare sector, growing healthcare expenditure and a huge patient population for coronary heart diseases, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to presence of developing economies such as India and China and a developing healthcare sector.

The country section of the angina market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Read More @

Healthcare Infrastructure growth Installed base and New Technology Penetration

Angina market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for angina market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the angina market. The data is available for historic period 2010 to 2018.

About Data Bridge Market Research: 

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @

Editor Details

  • Company:
    • The Wire Times
Last Updated: 09-Sep-2021